• Activity INFORMATION

  Overview

  There are already multiple cannabinoids that are FDA-approved to treat specific medical conditions. While some have been around for decades, plenty more in the pipeline of late-phase studies. In this discussion, we will dive deeper into the weeds of understanding the pharmacology and clinical care concerns of current prescription cannabinoids with respect to FDA approvals, dosage, drug interactions, and side effects. We will then discuss possible mechanistic endocannabinoid system (ECS) targets of future pharmaceutical and commercial cannabinoid products.
  

  Handouts

  • Slide Document :   23066H99_2pp.pdf Download

  • Slide Document :   23066H99_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify appropriate selection, dosing, and patient counseling concepts of drug interactions and side effects for all FDA-approved prescription cannabinoids

  Recall endocannabinoid system (ECS) mechanisms of action of novel cannabinoids currently being studied

  Recall the FDA-approved prescription cannabinoid products on the US market and medical conditions being treated

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-995016

  Universal Activity Number

  Pharmacist 0798-0000-23-066-H99-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).